Care program for children and teens with multiple allergies
Part of Immune system & allergy clinical trials.
This trial is for people with moderate to severe allergic diseases who are about to start a biologic medicine (a targeted allergy treatment). It also looks at people who have more than one allergy condition, aiming to improve coordinated care across allergy problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 6 years old
- Have a proven moderate to severe allergy condition
- Be planning to start a biologic medicine for allergy (systemic treatment)
- Have at least one additional confirmed allergy condition
- Not have fewer than two allergy conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment that slowly builds tolerance to multiple nut allergens (peanut and tree nuts) in children with allergies. It aims to reduce the risk of severe reactions from accidental exposure.
This trial tests a program to help teens with food allergies learn more about managing their condition and reduce its impact on daily life. It is for kids ages 10–14 who have had a common food allergy for at least one year.
This trial looks at treatment and medical care for teens and adults with moderate to severe atopic dermatitis (eczema). It may help by testing ways to manage symptoms better based on severity and current treatment needs.
This study is a long-term registry for adolescents and adults with atopic dermatitis (eczema) who are starting or switching to a systemic medication (a drug that works throughout the body). It will track how these treatments work in real life and how patients feel over time.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
Hear when a new Atopic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.